Tirzepatide (Mounjaro/Zepbound) is a dual GIP/GLP-1 receptor agonist that has shown even greater weight loss than semaglutide in head-to-head trials
If you experience prolonged vomiting lasting more than a day or two, or inability to keep down fluids, seek immediate medical advice as these could indicate serious conditions like pancreatitis or other gastrointestinal issues, urges Dr
Kim estimates that around 20% of the patients she sees might be able to maintain their loss
Therefore, patients should review safe alternatives with a qualified provider
This guide tells you how the treatment works, who can use it, what to expect, side effects, costs, and how it compares to other options
Ordered a lot of shots and never disappointed Came quickly So far so good